Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.42 - $0.72 $1,641 - $2,813
-3,908 Reduced 6.88%
52,876 $33,000
Q3 2023

Nov 14, 2023

SELL
$0.6 - $1.53 $1,506 - $3,841
-2,511 Reduced 4.23%
56,784 $34,000
Q2 2023

Aug 14, 2023

BUY
$1.05 - $1.63 $62,259 - $96,650
59,295 New
59,295 $67,000
Q3 2022

Nov 14, 2022

SELL
$1.9 - $8.63 $5,977 - $27,149
-3,146 Reduced 14.08%
19,197 $48,000
Q2 2022

Aug 15, 2022

SELL
$2.13 - $9.01 $9,295 - $39,319
-4,364 Reduced 16.34%
22,343 $53,000
Q1 2022

May 16, 2022

SELL
$6.28 - $15.59 $131,051 - $325,332
-20,868 Reduced 43.86%
26,707 $213,000
Q4 2021

Feb 10, 2022

SELL
$14.7 - $28.67 $658,927 - $1.29 Million
-44,825 Reduced 48.51%
47,575 $726,000
Q3 2021

Nov 15, 2021

BUY
$24.31 - $33.6 $371,481 - $513,441
15,281 Added 19.81%
92,400 $2.63 Million
Q2 2021

Aug 10, 2021

BUY
$26.09 - $40.4 $525,426 - $813,615
20,139 Added 35.34%
77,119 $2.6 Million
Q1 2021

May 12, 2021

BUY
$33.06 - $56.93 $770,628 - $1.33 Million
23,310 Added 69.23%
56,980 $2.18 Million
Q4 2020

Feb 11, 2021

BUY
$39.09 - $57.4 $205,965 - $302,440
5,269 Added 18.55%
33,670 $1.41 Million
Q3 2020

Nov 13, 2020

BUY
$28.43 - $44.67 $238,158 - $374,200
8,377 Added 41.83%
28,401 $1.23 Million
Q2 2020

Aug 04, 2020

BUY
$11.71 - $30.29 $234,481 - $606,526
20,024 New
20,024 $607,000
Q2 2019

Aug 12, 2019

SELL
$17.37 - $26.27 $13,114 - $19,833
-755 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$9.26 - $16.38 $6,991 - $12,366
755 New
755 $835,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Cresset Asset Management, LLC Portfolio

Follow Cresset Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.